A Window Into the HIV Epidemic from a South African Emergency Department.


Journal

AIDS research and human retroviruses
ISSN: 1931-8405
Titre abrégé: AIDS Res Hum Retroviruses
Pays: United States
ID NLM: 8709376

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 15 9 2018
medline: 13 2 2020
entrez: 15 9 2018
Statut: ppublish

Résumé

The aim of the study was to describe the HIV care continuum in emergency department (ED) patients in the Eastern Cape region of South Africa. This is a cross-sectional, identity-unlinked serosurvey, whereby discarded/excess samples from all patients who had blood drawn during the study period for routine care and sufficient serum remaining were tested for HIV, hepatitis B virus, and hepatitis C virus infection; HIV viral load (VL); and presence of antiretroviral (ARV) drugs. We also estimated cross-sectional incidence using the Limiting-Antigen Avidity assay and HIV VL. The study was conducted between September and November 2016 at the Frere Hospital Emergency Department in East London, South Africa. The overall HIV prevalence in our study population was 26.9% [95% confidence interval (CI): 25.0-28.8; n = 2,100]. The highest prevalence was observed among females in the 30-39 years age group [60.3% (95% CI: 53.2-67.1)]. HIV prevalence was significantly higher among females compared with males in both the 20-29 years age group and 30-39 years age group (p < .05), but nearly identical to older age groups. ARV drugs were detected in 53.5% (95% CI: 48.1-58.9) of HIV-infected subjects. The frequency of HIV viral suppression (< 1,000 copies/mL) was 48.5% (95% CI: 44.3-52.7), and was not statistically different between males and females (age-adjusted prevalence ratio = 1.15, 95% CI: 0.95-1.39). The HIV incidence rate was estimated to be 2.6% (95% CI: 1.2-3.9). The Frere Hospital ED has an extremely high burden of HIV infection. The detection of ARV drugs and prevalence of viral suppression fall short of the World Health Organization 90-90-90 goals in this population. Furthermore, there were a large number of patients with recent infection in the ED. The ED is a critical venue for testing and linkage to care of high-yield population who are likely missed by current testing and linkage-to-care programs.

Identifiants

pubmed: 30215268
doi: 10.1089/AID.2018.0127
pmc: PMC6360397
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-144

Références

Afr Health Sci. 2007 Sep;7(3):124-8
pubmed: 18052863
World J Surg. 2013 Sep;37(9):2122-8
pubmed: 23652356
Ann Emerg Med. 1990 Sep;19(9):963-9
pubmed: 2393180
S Afr Med J. 2000 Mar;90(3):251-5
pubmed: 10853402
S Afr Med J. 2008 Jul;98(7):541-4
pubmed: 18785395
Epidemiology. 2012 Sep;23(5):721-8
pubmed: 22627902
Am J Epidemiol. 1995 Jan 15;141(2):166-72
pubmed: 7817972
PLoS One. 2015 Jul 31;10(7):e0133255
pubmed: 26230949
JAMA. 1989 Jul 28;262(4):516-22
pubmed: 2739054
Am J Emerg Med. 2016 Feb;34(2):180-4
pubmed: 26589466
J Int AIDS Soc. 2016 Jun 09;19(1):20711
pubmed: 27293220
Health (London). 2011 Sep;15(5):491-516
pubmed: 21169208
PLoS One. 2018 Mar 13;13(3):e0193858
pubmed: 29534077
Int J Emerg Med. 2008 Dec;1(4):317-20
pubmed: 19384648
Ann Emerg Med. 2004 Jul;44(1):31-42
pubmed: 15226706
Ann Emerg Med. 2015 Jul;66(1):69-78
pubmed: 25720801
Am J Epidemiol. 2013 Feb 1;177(3):264-72
pubmed: 23302151
S Afr Med J. 2011 Jun 27;101(7):470-1
pubmed: 21920100
Afr J AIDS Res. 2016;15(1):67-75
pubmed: 27002359
PLoS Med. 2016 Aug 09;13(8):e1002107
pubmed: 27504637
J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):395-401
pubmed: 18077831
JAMA. 1998 Jul 1;280(1):42-8
pubmed: 9660362
BMC Public Health. 2018 Mar 2;18(1):303
pubmed: 29499668
Clin Chim Acta. 2014 Jun 10;433:157-68
pubmed: 24661980
AIDS. 2016 Jan 2;30(1):113-20
pubmed: 26731757
HIV Med. 2013 Nov;14(10):605-13
pubmed: 23773723
CMAJ Open. 2016 May 25;4(2):E240-8
pubmed: 27398370
AIDS Patient Care STDS. 2007 Dec;21(12):981-6
pubmed: 18154494
AIDS Patient Care STDS. 2012 Apr;26(4):202-7
pubmed: 22356726

Auteurs

Bhakti Hansoti (B)

1 Department of Emergency Medicine, The Johns Hopkins University, Baltimore, Maryland.

David Stead (D)

2 Department of Medicine, Frere and Cecilia Makiwane Hospitals, East London, South Africa.
3 Department of Medicine, Faculty of Health Sciences, Walter Sisulu University, East London, South Africa.

Anna Eisenberg (A)

4 Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, Maryland.

Nomzamo Mvandaba (N)

3 Department of Medicine, Faculty of Health Sciences, Walter Sisulu University, East London, South Africa.

George Mwinnyaa (G)

5 Department of Infectious Diseases, The Johns Hopkins University, Baltimore, Maryland.

Eshan U Patel (EU)

5 Department of Infectious Diseases, The Johns Hopkins University, Baltimore, Maryland.

Andy Parrish (A)

2 Department of Medicine, Frere and Cecilia Makiwane Hospitals, East London, South Africa.
3 Department of Medicine, Faculty of Health Sciences, Walter Sisulu University, East London, South Africa.

Steven J Reynolds (SJ)

4 Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, Maryland.
5 Department of Infectious Diseases, The Johns Hopkins University, Baltimore, Maryland.

Andrew D Redd (AD)

4 Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, Maryland.
5 Department of Infectious Diseases, The Johns Hopkins University, Baltimore, Maryland.

Reinaldo Fernandez (R)

5 Department of Infectious Diseases, The Johns Hopkins University, Baltimore, Maryland.

Richard E Rothman (RE)

1 Department of Emergency Medicine, The Johns Hopkins University, Baltimore, Maryland.

Oliver Laeyendecker (O)

4 Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, Maryland.
5 Department of Infectious Diseases, The Johns Hopkins University, Baltimore, Maryland.

Thomas C Quinn (TC)

4 Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, Maryland.
5 Department of Infectious Diseases, The Johns Hopkins University, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH